Weather in the tropics is decidedly different than it is in the middle latitudes. It turns out, so are the weather systems – the factors that create things like the daily temperature and humidity! Historically, most weather forecasting models have been based on data from high-income countries in the northern hemisphere. But different factors drive weather and climate near the equator – meaning that these weather forecast models are much less accurate at predicting weather in the tropics. This has

Send us a text Grief doesn’t arrive with instructions, and it rarely follows a neat timeline. We sit down with Liam, 14, and Toan, 22, to explore how losing a father at the age of eight years old, reshapes identity, school, friendships, and the rhythm of home. Their losses are different—motor neurone disease in one family, alcoholism in the other—but their insights echo: funerals make reality land, support matters most when it’s quiet and consistent, and rituals help turn pain into presence. ...

The launch of ChatGPT three years ago brought the concept of artificial intelligence into the daily conversation. Today, it seems all industries, including lab medicine, are integrating AI with the promise of making our lives easier. How do we best navigate implementing this technology into clinical microbiology? How will it be regulated? … and, what is AI anyway? Watch this epsiode: https://youtu.be/2B_JJEFJv7I Guests: Dr. Susan Sharp Dr. Kendall Bryant Links:  Proceedings of the Clinical

This special episode features Dr. Monique Smith (Assistant Professor, UCSD) discussing faculty job applications with host Dr. Nancy Padilla-Coreano.

Coming Soon: Invictus.Reviews YouTube Version We reframe “drowning” as submersion incidents and lay out a simple path from shore to safe disposition. Hypoxia drives arrest, observation prevents misses, and ECMO has a clear role when ventilation fails or hypothermia persists. • replacing drowning with submersion incidents • hypoxia as the primary cause of arrest • selective C‑spine precautions based on mechanism • ECMO for refractory hypoxemia or hypothermia • normal chest X‑ray can mislead a...

In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Tarun Vemulkar, CTO and Co-Founder of Semarion, to explore how their groundbreaking SemaCyte® platform is reshaping the way scientists handle, study, and analyze cells. They dive into the intersection of materials science and cell biology, unpacking how Semarion’s smart materials enable faster, more reproducible cell-based assays — ultimately accelerating the path from discovery to therapy.What You’ll Hear:The

The global MedTech regulatory landscape is notoriously complex. While established firms like Freyr Solutions have been a traditional choice, the industry is shifting towards more agile, technology-driven partners. This episode explores the limitations of legacy models and introduces a modern framework for achieving faster, more cost-effective global market access.We delve into the concept of a "single process, multiple markets" strategy, powered by AI and a network of local experts. Discover how

In this edition of The Naked Scientists: Is elite level sport linked with Motor Neurone Disease? We examine the evidence as another top player announces his diagnosis. Also, cages that can sieve out molecules, the immune system peacekeepers; and the quantum realm: we look at this year's Nobel Prizes for science. And, how did birds react to the Great American Eclipse last year? Like this podcast? Please help us by supporting the Naked Scientists

As pharmaphorum reported during ESMO 2025, fresh from a return to oncology with the FDA approval of zongertinib as a treatment for HER2-positive non-small cell lung cancer (NSCLC), tumour shrinkage observed by investigator review - Boehringer Ingelheim is racing to expand its label.As the company reported new data at the Congress from the phase 1b Beamion LUNG-1 study, underpinning the approval of zongertinib (Hernexeos) as a second-line therapy, web editor Nicole Raleigh spoke with Lykke Hinsch

Hi, it is once again my favourite time of the week, where we play the best game: count how many times Santina says "um" or "and so" while talking about science. Also, the words "and so" look like a fish on my audio editing platform, thanks to Audacity. This week, I talk about some of my previous work looking at cerebral (brain) blood flow: specifically, two processes known as neurovascular coupling and cerebrovascular reactivity. We in particular look at the effects of acute hyperglycemia, or a

In this episode of LATAM MedTech Insights, we explore why a one-size-fits-all approach to entering the Latin American medical technology market is a recipe for failure. The region is not a monolith but a collection of unique countries, each with its own distinct regulatory, economic, and healthcare systems. Success depends on moving beyond surface-level data and leveraging deep market intelligence.We dissect how granular market briefs provide the critical insights needed to build a winning

Where Policy Meets the Pharmacy CounterFeaturing Congressman Jake Auchincloss Episode Summary In this episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with Congressman Jake Auchincloss (MA-04) to dissect the tangled web of policy, profit, and politics driving America’s drug pricing system. From pharmacy benefit managers (PBMs) to the politics of tariffs, this discussion explores the push for transparency, fair competition, and sustainable reform in healthcare. Auchincloss, a Marine

Kymera Therapeutics has a clear mission: to transform immunology with targeted protein degraders that enable “oral drugs with biologics-like activity,” CEO Nello Mainolfi told The BioCentury Show. A pioneer in one of biopharma’s most closely watched new therapeutic modalities, Kymera is now over nine years into its story, with multiple pharma partnerships and a wholly owned pipeline, including a STAT6 degrader that produced promising data in June. In conversation with BioCentury’s Selina Koch...

In this second half of our discussion with Dr. Erin McCreary and Dr. Hannah Creager, we dive deeper into how microbiology and antimicrobial stewardship teams collaborate to improve patient outcomes. They unpack how to prioritize breakpoint updates, the pros and cons of cascade reporting, and what nudges can do to guide better prescribing. Then we explore a powerful example of collaboration—the transition from MRSA agar to PCR across hospitals—and what it taught both teams about communication,

In this episode of ASEAN MedTech Insights, we explore the critical importance of a harmonized yet localized labeling strategy for medical device companies targeting Southeast Asia. While the ASEAN Medical Device Directive (AMDD) promotes English as the standard for technical dossiers, relying solely on an English-first approach tailored for markets like Singapore can create significant barriers to entry in countries with specific national language requirements, such as Thailand and Indonesia.We

This episode of MENA MedTech Insights dives into the critical regulatory nuances for medical device companies expanding into the MENA region, particularly those with existing EU supply chains and approvals. We uncover why a CE mark is only the beginning of the journey and explore the growing divergence between EU standards, like EUDAMED, and the specific requirements of key markets like Saudi Arabia and the UAE. We break down the common assumption that EU compliance guarantees smooth entry into the

Chuck Scheper, Board Chair at Bexion Pharmaceuticals, shares how a stage IV non-Hodgkin lymphoma diagnosis at age 39 and a life-saving clinical trial led to his lifelong commitment to cancer research. He joins Tim Schroeder, CEO and Chairman of CTI, to discuss the founding of VaxCella, the evolution of cancer therapies, the importance of patient-centered research, and the role of collaboration in advancing drug development, highlighting resilience, innovation, and the impact of clinical

In this sinister episode from Stuff to Blow Your Mind, Robert and Joe discuss different folkloric and legendary monsters tied to mine shafts and mining...See omnystudio.com/listener for privacy information.

This month on Episode 77 of Discover CircRes, host Cindy St. Hilaire highlights articles featured in the September 26th and October 10th issues of Circulation Research. This Episode also features a discussion with Dr Camilla Wenceslau and Dr Laena Pernomian about their study, Single-Short Partial Reprogramming of the Endothelial Cells Decreases Blood Pressure Via Attenuation of EndMT in Hypertensive Mice. Article highlights: Brito-Estrada, et al. DWORF Gene Therapy Attenuates Heart Failure